value proposition slide deck - corail pinnacle · 2 overview this slide deck has been developed to...
TRANSCRIPT
Value messaging and accompanying evidence
identified from the Direct Anterior Approach
(DAA) and CORAIL®/PINNACLE® systematic
reviews
Version 9.0
15 April 2016
VALUE PROPOSITION SLIDE DECK
DSEM/JRC/0116/0614 April 2016
2
Overview
• This slide deck has been developed to summarise the evidence (identified in 2 previously commissioned systematic
reviews, and a more recently published literature review) that will be used in the developement of an evidence-based
value proposition to support DePuy Synthes Companies commercial strategy:
o Advocating the DAA as the primary surgical option for THA
o Consideration of CORAIL/PINNACLE as components of choice for THA
o Use of a traction table as an integral component for THA
• The slide deck is divided into 2 sections (DAA and CORAIL/PINNACLE) with separate appendices for each section
provided at the end of the slide deck. Results that favour DAA or CORAIL/PINNACLE or are neutral are presented
under value messages. Results that contradict the value messages identified are also presented after each value
message (where relevant). Details of systematic review methodology are presented in appendices
o Where feasible, we have identified evidence specific to the use of a traction table
• The purpose of this deck is to summarise the value messaging developed, and the evidence that supports it
3
Colour coding
• Each section of the evidence review begins with a table summarising the evidence identified by outcome. In this
table, the strength of evidence for each outcome is evaluated and colour coded: green indicates strong/reasonably
strong evidence, orange indicates moderate strength of evidence, and red indicates weak evidence
• In the DAA section, comparative evidence for each outcome is colour coded according to whether the evidence is in
favour of DAA, neutral, or not favourable for DAA:
o Green outlines indicate evidence that is in favour of DAA
o Orange outlines indicate evidence that is neutral for DAA
o Red outlines indicate evidence that is not favourable for DAA (appendices only)
o Non-comparative evidence is outlined in dark blue
• In the DAA section, studies reporting the operating table(s) used are indicated in bold text
• In the CORAIL/PINNACLE section, all evidence presented is non-comparative. In the absence of comparative data,
evidence have been marked as favourable (outlined in green) or not favourable (outlined in red) based on
benchmarks as described in the notes section of this slide
4
Assumptions
Favourable/non-favourable outcomes in non-comparative studies:
• Theatre time: A good outcome for theatre time was considered to be 60-90 minutes(1)
• Length of stay: A good outcome for length of stay was considered to be 3-5 days(2)
• Revision rate/survivorship: A good outcome for revision rate/survivorship (depending on follow-up time) was ≥95% at 10 years survival
(3)
• Radiographic outcomes: For stem subsidence, no clinically significant ≥3 mm may be acceptable at short follow-up:
Medical (Mick Borroff). For cup migration, no clinically significant ≥1 mm was considered acceptable: Medical (Mick
Borroff)
• Harris Hip Score: (pain, function, deformity, range of motion):<70 poor: -, 70–80 fair: 0, 80–90 good: +, 90–100
excellent : +
• Oxford Hip Score: (pain & function scores; daily activities, e.g. walking & sleeping):<27 poor: -, 27–33 fair: 0, 34–41
good: +, >41 excellent: +
• WOMAC: (pain, stiffness and function): depending on version of scale used, higher is better or lower is better
5
Abbreviations
• C/P CORAIL/PINNACLE
• DAA Direct Anterior Approach
• HHS Harris hip score
• ICU Intensive care unit
• IQR Interquartile range
• LOS Length of stay
• NJR National joint registry
• NS Not significant
• OHS Oxford hip score
• RCT Randomised controlled trial
• SD Standard deviation
• THA Total hip arthroplasty
• VAS Visual analogue scale
• WOMAC Western Ontario and McMaster Universities Arthritis Index
Value theme 1: Inpatient value
• Theatre time
• Length of stay
Comparative studies reporting evidence in
favour of DAA are outlined in green
Comparative studies reporting neutral
evidence for DAA are outlined in orange
Non-comparative studies are outlined in dark
blue
7
Duration of surgery does not increase with DAA compared with other
widely-used THA approaches, and decreases with surgeon experience of
DAA
8
Theatre time is generally similar for DAA and other widely-used THA approaches (1)
Supporting evidence Study details and patient population
Evidence comparing DAA with the anterolateral approach
• In a prospective cohort study, theatre time was similar between patients who underwent THA using the DAA, the
anterolateral approach, or the Hardinge lateral approach(4)
Prospective cohort
study (Romania)
N=180; patients who underwent THA
using either the DAA (n=60), the
anterolateral approach (n=60), or the
Hardinge lateral approach (n=60)
• In a RCT comparing patients who underwent THA using either the DAA or the modified anterolateral approach,
no significant difference in the mean duration of surgery was reported between the study arms(5)
RCT (Japan) N=201 (hips); patients who underwent
THA using either the DAA (n=100
hips) or the modified anterolateral
approach (n=101 hips)
• In a RCT comparing patients who underwent THA using either the DAA or the anterolateral approach, the mean
duration of surgery was similar between groups. The mean (range) duration of surgery was 70 (60-85) minutes in
the DAA group and 70 (60-89) minutes in the anterolateral approach group(6)
RCT (Austria) N=33; patients who underwent primary
THA using either the DAA (n=16) or
the anterolateral approach (n=17)
Evidence comparing DAA with the lateral approach
• The mean±SD operative time was significantly shorter in patients who underwent THA using the DAA
(132.52±24.68 minutes) compared with those who underwent THA using the direct lateral approach
(140.23±27.38 minutes) (p=0.006)(7)
Retrospective
analysis (USA)
N=319; patients who underwent THA
using the DAA (n=75) or the direct
lateral approach (n=244)
9
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach ctd.
• In a retrospective review of patients who underwent THA and were prospectively entered into a clinical database,
the mean duration of surgery was similar for THA using the anterior supine intermuscular approach (69 minutes)
and the direct lateral approach (68 minutes) (p=0.7)(8)
Retrospective review
(country not reported)
N=630; patients (main diagnosis of
osteoarthritis) who underwent primary
THA using the anterior supine
intermuscular approach (n=258) or the
direct lateral approach (n=372)
• In a prospective cohort study, theatre time was similar for patients who underwent THA using the DAA, the
anterolateral approach, or the Hardinge lateral approach(4)
Prospective cohort
study (Romania)
N=180; patients who underwent THA
using either the DAA (n=60), the
anterolateral approach (n=60), or the
Hardinge lateral approach (n=60)
• In a RCT comparing patients who underwent THA using either the DAA or the direct lateral approach, the
approaches were associated with a similar duration of surgery. The mean (range) duration of surgery was 57 (35-
90) minutes in the DAA group and 55 (36-100) minutes in the direct lateral approach group(9)
RCT (USA) N=79; patients who underwent THA
using either the DAA (n=43) or the
direct lateral approach (n=36)
• In a RCT comparing patients who underwent primary THA using a DAA or the direct lateral approach, there was
no significant difference between groups in terms of the mean duration of surgery (p=0.54). The mean (range)
duration of surgery was 56.42 (35-90) minutes in the DAA group and 54.88 (36-100) minutes in the direct lateral
approach group(10)
RCT (USA) N=100; patients with a diagnosis of
arthritis who underwent primary THA
using either single-incision Smith-
Peterson DAA (n=50) or the direct
lateral approach (n=50)
• In a prospective analysis comparing patients who underwent THA using either the DAA or the lateral
transgluteal approach, there was no significant difference between groups in terms of the mean duration
of surgery (p value reported as not significant). The mean (range) duration of surgery was reported as 78
(65-140) minutes in the DAA group and 85 (70-115) minutes in the lateral transgluteal approach group(11)
Prospective
analysis (Croatia)
N=70; patients who underwent THA
using either the DAA with a
standard orthopaedic table with a
leg holder (n=35) or the lateral
transgluteal approach (n=35)
Theatre time is generally similar for DAA and other widely-used THA approaches (2)
10
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a prospective analysis of patients who underwent THA using either the Hueter, Moor, or Gibson’s approach,
there was statistically significant variation regarding the duration of surgery between patients in the Hueter
approach group and those in the Moor or Gibson’s approach groups (p=0.0000 for both). There was no
statistically significant variation regarding duration of surgery between patients undergoing THA using the Moor
approach or the Gibson’s approach (p=0.1374)(12)
Prospective analysis
(Bosnia and
Herzegovina)
N=126; patients who underwent
primary THA using the Hueter (most
medial [n=34]), Moor (n=56), or
Gibson’s posterolateral (n=46)
approach
• The mean±SD operative time was significantly shorter in patients who underwent THA using the DAA (78±17.9
minutes) compared with those who underwent THA using the posterior approach (118±19.4 minutes)
(p=0.00)(13)
Prospective analysis
(USA)
N=57; patients with osteoarthritis who
underwent primary THA using the DAA
(n=29) or the posterior approach
(n=28)
• In a retrospective analysis comparing patients who underwent THA using one of two minimally invasive
approaches, there was no significant difference in the mean duration of surgery between patients who underwent
THA using the DAA (mean±SE: 104.7±2.9 minutes) and those who underwent THA using the mini-posterior
approach (mean±SE: 100.4±3.0 minutes) (p=0.304)(14)
Retrospective
analysis (Japan)
N=182 (195 hips); patients with a
primary diagnosis of secondary
osteoarthritis who underwent THA
using either the DAA (n= 99 hips) or
the mini-posterior approach (n=96
hips)
• In a prospective analysis comparing patients who underwent THA using either the anterior approach or the
posterolateral approach, there was no significant difference between groups in terms of the mean duration of
surgery (p=0.056). The mean duration of surgery was 99.5 minutes in the anterior approach group and 81
minutes in the posterolateral approach group(15)
Prospective analysis
(The Netherlands)
N=20; patients who underwent THA
using either the anterior approach
(n=10) or the posterolateral approach
(n=10)
Theatre time is generally similar for DAA and other widely-used THA approaches (3)
11
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach ctd.
• In a prospective comparison between patients who underwent THA using either the DAA or the posterior
approach, there was no significant difference between groups in terms of the mean duration of surgery
(p=0.09). The mean±SD duration of surgery was 90±15 minutes in the DAA group and 85±14 minutes in
the posterior approach group(16)
Prospective
comparative study
(USA)
N=120; patients with unilateral
osteoarthritis of the hip who
underwent primary THA using the
DAA (using a standard operating
table and a table-mounted femoral
elevator) (n=60) or the posterior
approach (n=60)
• In a retrospective chart review comparing patients who underwent primary THA using either the DAA or the
posterior approach, there was no significant difference between groups in terms of the mean duration of surgery
(p=0.205). The mean±SE duration of surgery was 109±3.2 minutes in the DAA group and 102±3.8 minutes in
the posterior approach group(17)
Retrospective chart
review (USA)
N=200; patients who underwent THA
using either the DAA (n=100) or the
posterior approach (n=100) with a
CORAIL stem and a PINNACLE cup
• In a retrospective review of patients who underwent THA using either the DAA as part of the surgeon’s learning
curve, the DAA following the initial learning curve, or the posterior approach, there was no significant difference
between the DAA following the initial learning curve and the posterior approach in terms of the duration of
surgery (mean±SD 82.4±16.6 minutes for the DAA and 87.8±20.0 minutes for the posterior approach;
p=0.3433). During the learning curve for the DAA, the mean duration of surgery (mean±SD: 102.7 minutes) was
significantly higher than for THA using the DAA following the initial learning curve and using the posterior
approach (p<0.0001 and p<0.0005, respectively)(18)
Retrospective review
(USA)
N=150; patients who underwent THA
using either the DAA (n=50 during the
surgeon’s learning curve and n=50
subsequent cases), the posterior
approach (n=50)
Theatre time is generally similar for DAA and other widely-used THA approaches (4)
12
Contradictory evidence Study details and patient population
Evidence comparing DAA with the lateral approach
• In a retrospective analysis, the DAA was associated with a mean±SD surgery time of 89±19 minutes,
compared with a mean±SD surgery time of 81±15 minutes in patients who underwent THA using the lateral
approach(19)
Retrospective
analysis (Italy)
N=419; patients who underwent
primary THA (main diagnosis was
coxarthrosis) using either the DAA
(n=221) or lateral approach (n=198)
• In a prospective cohort study, the median duration of surgery was longer for patients undergoing THA using the
minimally invasive anterior approach compared with the lateral trangluteal approach (119 vs 107 minutes;
p<0.001)(20)
Prospective cohort
study (Switzerland)
N=255; patients undergoing elective
primary THA using the minimally
invasive anterior approach with a
standard trauma table (n=113) or the
standard lateral transgluteal approach
(n=142)
• In a prospective analysis, the anterior supine intermuscular approach was associated with a significantly longer
mean theatre time compared with the modified Hardinge approach (73 vs 56 minutes; p<0.01)(21)
Prospective analysis
(USA)
N=259; patients who underwent
primary THA using either the anterior
supine intermuscular approach
(n=182) or the modified Hardinge
approach (n=77)
• In a retrospective analysis, patients who underwent THA using the anterior mini-invasive approach had a
significantly longer operative time than patients who underwent THA using the lateral Hardinge approach
(p<0.001)(22)
Retrospective
analysis (country not
reported)
N=200; patients who underwent THA
using either the anterior mini-invasive
approach (n=100) or the lateral
Hardinge approach (n=100)
Contradictory evidence: Theatre time is generally similar for DAA and other widely-
used THA approaches (1)
13
Contradictory evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a RCT comparing THA using the DAA with THA using the posterolateral approach, the operative time was
longer for the DAA group (p<0.05)(23)
RCT (USA) N=88; patients who underwent THA
(main diagnosis was osteoarthritis)
using either the DAA (n=43) or the
posterolateral approach (n=45)
• In a RCT comparing THA using the DAA with THA using the posterolateral approach, the mean±SD
surgery time was 84.3±12.4 minutes in the DAA group and 60.5±12.4 in the posterolateral approach
group(24)
RCT (USA) N=87; patients with non-
inflammatory degenerative joint
disease who underwent primary
THA (with a CORAIL stem and a
PINNACLE cup) using the DAA with
a modern fracture table and a C-arm
(n=43) or the posterolateral
approach (n=44)
• In a retrospective comparative study, mean±SD operative time was 103±18 minutes in the DAA learning
curve group, 90±15 minutes in the DAA group, and 84±14 minutes in the posterior approach group(25)
Retrospective
comparative study
(USA)
N=677; patients who underwent
primary THA using the DAA
(n=286), the posterior approach
with a standard operating table and
table-mounted femoral elevator,
and with fluoroscopy (n=293), or
those forming part of the DAA
learning curve (n=96)
Contradictory evidence: Theatre time is generally similar for DAA and other widely-
used THA approaches (2)
14
Theatre time for DAA is generally 60-90 minutes, with times as low as 52 minutes
reported (1)
Supporting evidence Study details and patient population
Non-comparative evidence for DAA
• In a prospective analysis of 100 primary THAs using the Smith-Peterson DAA with a HANA traction table,
the mean (range) duration of surgery was 53 (34-87) minutes(26)
Prospective review
(USA)
N=100; consecutive patients who
underwent THA using the Smith-
Peterson DAA
• In a retrospective analysis of 906 patients who underwent THA using the anterior supine intermuscular approach,
the mean (range) duration of surgery was 63.6 (10-143) minutes(27)
Retrospective
analysis (country not
reported)
N=906; patients who underwent
primary or revision THA using the
anterior supine intermuscular
approach
• In a retrospective analysis of 824 patients who underwent THA using the anterior supine intermuscular approach,
the mean (range) duration of surgery was 63.1 (29-143) minutes(28)
Retrospective
analysis (USA)
N=824; patients who underwent THA
using the anterior supine
intermuscular approach
• In a prospective analysis of 500 patients who underwent primary THA using the Smith-Peterson DAA with
a traction table (ProFX or HANA), the mean (range) duration of surgery was 70 (45-132) minutes(29)
Prospective
analysis (USA)
N=500; patients who underwent
primary THA using the Smith-
Peterson DAA with a ProFX or a
HANA traction table
• In a prospective analysis of 100 patients who underwent primary THA using the DAA with a Rotex table
and a modified retractor system, the mean (range) duration of surgery was 80 (55-130) minutes(30)
Prospective
analysis
(Switzerland)
N=100; patients who underwent
primary THA using the DAA with a
Rotex table and modified retractor
system
• In a retrospective analysis of 100 patients who underwent primary THA using the DAA with a leg-
positioner Rotex table, the mean±SD duration of surgery was 81±14.6 minutes(31)
Retrospective
analysis (country
not reported)
N=100; patients (main diagnosis
was osteoarthritis) who underwent
primary THA using the DAA with a
leg-positioner Rotex table
15
Supporting evidence Study details and patient population
Non-comparative evidence for DAA ctd.
• In a retrospective analysis of 903 patients who underwent THA using the anterior approach, the mean (range)
duration of surgery was 88 (35-330) minutes(32)
Retrospective
analysis (USA)
N=903; patients who underwent
primary or revision THA using the
anterior approach
• In a retrospective analysis of patients who underwent THA using a cemented or cementless stem with a
noncomplex or complex anterior approach, the mean±SD duration of surgery for each of the combinations were:
51±13.2 minutes for the cemented stem/noncomplex anterior approach, 76±27.5 minutes for the cemented
stem/complex anterior approach, 60.4±15 minutes for the cementless stem/noncomplex anterior approach, and
82.9±29.6 minutes for the cementless stem/complex anterior approach(33)
Retrospective
analysis (USA)
N=2,132; patients who underwent THA
using a cemented stem and
noncomplex anterior approach
(n=1,177) or complex anterior
approach (n=104), or a cementless
stem and noncomplex anterior
approach (n=672) or complex anterior
approach (n=179)
• In a retrospective analysis, patients who underwent THA using a conventional DAA had a mean±SD duration of
surgery of 61±15.8 minutes compared with a mean duration of 56±10.7 minutes in patients who underwent
THA using a DAA with computer navigation (p<0.0001)(34)
Retrospective chart
review (USA)
N=300; patients who underwent
primary THA using either the
conventional DAA (n=150) or a
navigation DAA (n=150)
• In a retrospective analysis of patients who underwent THA using the anterior approach, the mean (range)
duration of surgery was 64 (35-130) minutes(35)
Retrospective
analysis (USA)
N=85; patients who underwent primary
or revision THA using the anterior
approach
• In a retrospective analysis of patients who underwent bilateral THA using the anterior approach with a
Judet or ProFX table, the mean (range) duration of surgery was 1.14 (0.66-2.33) hours(36)
Prospective
analysis (USA)
N=147; patients who underwent
simultaneous bilateral THA using
the anterior approach with a Judet
or ProFX table
Theatre time for DAA is generally 60-90 minutes, with times as low as 52 minutes
reported (2)
16
Supporting evidence Study details and patient population
Non-comparative evidence for DAA ctd.
• In a retrospective analysis of patients who underwent primary THA using the single-incision anterior
approach with a Judet or ProFX table, the mean (range) duration of surgery was 75 (40-150) minutes(37)
Retrospective
analysis (USA)
N=437; patients who underwent
primary THA using the single-
incision anterior approach with a
Judet or ProFX table
• The mean duration of surgery was 1.5 hours in patients who underwent primary THA using the anterior
approach(38)
Retrospective
analysis (USA)
N=465; patients who underwent
primary THA using the anterior
approach with a Judet or ProFX
table
• The mean duration of surgery in patients who underwent THA using the DAA was 58 minutes(39) Prospective analysis
(Iran)
N=101; patients who underwent
primary THA using the DAA
• The mean duration of surgery in patients who underwent THA using the anterior approach was 67.4 minutes(40) Prospective analysis
(USA)
N=356; patients who underwent
primary THA using the anterior
approach
• The mean (range) duration of surgery in patients who underwent THA using the DAA was 79 (45-150) minutes(41) Prospective analysis
(Japan)
N=95; patients who underwent primary
THA (main diagnosis was
osteoarthritis) using the DAA
• The mean duration of surgery in patients who underwent THA using the DAA was 87 minutes(42) Retrospective
analysis (USA)
N=668; patients who underwent THA
using the DAA
• The mean (range) duration of surgery in patients who underwent THA using the minimally invasive anterior
approach was 52 (45-130) minutes(43)
Prospective analysis
(country not reported)
N=1,000; patients who underwent THA
using the anterior minimally invasive
approach
Theatre time for DAA is generally 60-90 minutes, with times as low as 52 minutes
reported (3)
17
Contradictory evidence: Theatre time for DAA is generally 60-90 minutes, with
times as low as 52 minutes reported Contradictory evidence Study details and patient population
Non-comparative evidence
• In a retrospective analysis of 1,152 patients who underwent primary THA using the single incision anterior
approach, the mean±SD operative time was 95.3±34.9 minutes(44)
Retrospective
observational study
(USA)
N=1,152; patients who underwent
primary THA using the single incision
anterior approach
• In patients with and without paresthesia, mean±SD operative times were 123.8±5.9 minutes and 112.9±2.5
minutes, respectively(45)
Retrospective chart
review (country not
reported)
N=81; hips undergoing anterior supine
THA (patients with or without
paresthesia)
• In a retrospective analysis of patients who underwent THA using the DAA, the mean±SD time of surgery was
114±28.9 minutes(46)
Retrospective
analysis (Sweden)
N=200; consecutive cases of unilateral
THA using the DAA
• In a RCT including patients who underwent THA using the DAA, the mean±SD (range) surgical time was
115±26 (60-180) minutes(47)
RCT (Switzerland) N=120; patients with osteoarthritis who
underwent THA using the DAA with an
extension-distraction table (AMIS
mobile leg positioner) and either no
drain (n=40), a closed suction 3.5 mm
drain connected to a vacuumed (−900 mbar) drainage bottle (n=40), or an
ABTrans autologous retransfusion
system (n=40)
• Mean surgery time was 132.8 minutes in the first 100 THA cases, 109.9 minutes in the second 100 cases,
and106.1 minutes in the third 100 cases(48)
Retrospective review
(USA)
N=300; THAs performed using the
DAA (cases were grouped [in 100s]
based on chronological order)
• The mean (range) surgical time in patients who underwent primary THA using the anterior approach with an OSI
Profix table was 164 (81-378) minutes(49)
Retrospective
analysis (USA)
N=231 (247 hips); patients who
underwent primary THA using the
anterior approach with an OSI Profix
table
18
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a retrospective review of patients who underwent THA using either the DAA as part of the surgeon’s learning
curve, the DAA following the initial learning curve, or the posterior approach, there was no significant difference
between the DAA following the initial learning curve and the posterior approach in terms of the duration of
surgery (mean±SD: 82.4±16.6 minutes for the DAA and 87.8±20.0 minutes for the posterior approach;
p=0.3433). During the learning curve for the DAA, the mean duration of surgery (mean±SD: 102.7 minutes) was
significantly higher than for THA using the DAA following the initial learning curve and using the posterior
approach (p<0.0001 and p<0.0005, respectively)(18)
Retrospective review
(USA)
N=150; patients who underwent THA
using either the DAA (n=50 during the
surgeon’s learning curve and n=50
subsequent cases), or the posterior
approach (n=50)
Duration of surgery decreases with surgeon experience of DAA
19
Theatre time is generally similar for DAA and other widely-used THA approaches, including the anterolateral, lateral, and posterior approaches
Theatre time for DAA is generally 60-90 minutes with times as low as 52 minutes reported
Duration of surgery decreases with surgeon experience of DAA
Duration of surgery does not increase with DAA compared with other
widely-used THA approaches, and decreases with surgeon experience of
DAA
20
Evidence indicates that length of stay can be reduced with DAA compared
with lateral and posterior approaches, and decreases with surgeon
experience of DAA
21
Length of stay is similar or reduced with DAA compared with lateral and posterior
approaches (1)
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach
• The mean length of hospital stay was significantly lower in patients who underwent primary THA using the DAA
compared with those who underwent THA using the lateral approach, with a mean±SD length of stay of
7±2 days in the DAA group and 10±3.5 days in the lateral approach group (p<0.0005)(19)
Retrospective
analysis (Italy)
N=419; patients who underwent
primary THA (main diagnosis was
coxarthrosis) using either the DAA
(n=221) or lateral approach (n=198)
• In a retrospective analysis of patients who underwent primary THA using either the anterior approach or the
lateral approach, length of stay was significantly associated with approach (lateral vs anterior approach, odds
ratio 3.38 [95% CI: 2.14-5.33], p<0.0001)(50)
Retrospective
analysis
(The Netherlands)
N=477; patients who underwent
primary THA in a fast-track setting
using either the anterior approach or
the lateral approach
• The mean length of hospital stay was significantly lower in patients who underwent primary THA using the
modified Smith-Peterson DAA compared with those who underwent THA using the Bauer approach, with a
mean±SD length of stay of 10.2±8.3 days in the DAA group and 13.4±11.7 days in the Bauer approach group
(p=0.0001)(51)
Retrospective
analysis (Germany)
N=200; patients who underwent THA
using either the modified Smith-
Peterson DAA (n=100) or the Bauer
approach (n=100)
22
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach ctd.
• In a prospective cohort study, the median duration of hospitalisation was significantly shorter in the minimally
invasive surgery group than the standard lateral transgluteal group (11.0 vs 12.0 days; p<0.001)(20)
Prospective cohort
study (Switzerland)
N=255; patients undergoing elective
primary THA using the minimally
invasive anterior approach with a
standard trauma table (n=113) or the
standard lateral transgluteal approach
(n=142)
• In a retrospective analysis, patients who underwent THA using the anterior mini-invasive approach had a
significantly shorter hospital stay than patients who underwent THA using the lateral Hardinge approach
(p<0.001)(52)
Retrospective
analysis (country not
reported)
N=200; patients who underwent THA
using either the anterior mini-invasive
approach (n=100) or the lateral
Hardinge approach (n=100)
• No significant difference was reported in the mean length of stay of patients who underwent primary THA using
the anterior supine intermuscular approach (1.8 days) compared with those who underwent primary THA using
the direct lateral approach (2 days) (p=0.1)(8)
Retrospective review
(country not reported)
N=630; patients (main diagnosis of
osteoarthritis) who underwent primary
THA using the anterior supine
intermuscular approach (n=258) or the
direct lateral approach (n=372)
• In a RCT comparing patients who underwent THA using the DAA or the direct lateral approach, the mean length
of stay was 2.7 days in the DAA group and 2.5 days in the direct lateral approach group(9)
RCT (USA) N=79; patients who underwent THA
using either the DAA (n=43) or the
direct lateral approach (n=36)
• In a RCT comparing patients who underwent primary THA using a DAA or the direct lateral approach, there was
no significant difference between groups in terms of the mean length of stay (p=0.56). The mean (range) length
of stay was 3.56 (3-5) days in the DAA group and 3.50 (3-6) days in the direct lateral approach group(10)
RCT (USA) N=100; patients with a diagnosis of
arthritis who underwent primary THA
using either single-incision Smith-
Peterson DAA (n=50) or the direct
lateral approach (n=50)
Length of stay is similar or reduced with DAA compared with lateral and posterior
approaches (2)
23
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach ctd.
• In a prospective analysis comparing patients who underwent THA using either the DAA or the lateral
transgluteal approach, there was no significant difference between groups in terms of the mean length of
stay (p value reported as not significant). The mean (range) length of stay was reported as 10 (7-12) days
in the DAA group and 12 (9-14) days in the lateral transgluteal approach group(11)
Prospective
analysis (Croatia)
N=70; patients who underwent THA
using either the DAA with a
standard orthopaedic table with a
leg holder (n=35) or the lateral
transgluteal approach (n=35)
• In a prospective analysis comparing patients who underwent THA using either the anterior supine intermuscular
approach or the modified Hardinge approach, there was no significant difference between groups in terms of the
mean length of stay (p>0.1). The anterior supine intermuscular approach was associated with a mean length of
stay of 1.9 days and the modified Hardinge approach was associated with a mean length of stay of 2 days(21)
Prospective analysis
(USA)
N=259; patients who underwent
primary THA using either the anterior
supine intermuscular approach
(n=182) or the modified Hardinge
approach (n=77)
Evidence comparing DAA with the posterior approach
• The mean length of hospital stay was significantly lower in patients who underwent primary THA using the DAA
(2.3 days) compared with those who underwent THA using the posterolateral approach (2.7 days) (p=0.0004)(23)
RCT (USA) N=88; patients who underwent THA
(main diagnosis was osteoarthritis)
using either the DAA (n=43) or the
posterolateral approach (n=45)
• The mean length of hospital stay was significantly lower in patients who underwent primary THA using
the DAA with a modern fracture table (2.28 days) compared with those who underwent THA using the
posterolateral approach (3.02 days) (p=0.0374)(24)
RCT (USA) N=87; patients with non-
inflammatory degenerative joint
disease who underwent primary
THA (with a CORAIL stem and a
PINNACLE cup) using the DAA with
a modern fracture table and a C-arm
(n=43) or the posterolateral
approach (n=44)
Length of stay is similar or reduced with DAA compared lateral and posterior
approaches (3)
24
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach ctd.
• The mean length of hospital stay was significantly lower in patients who underwent primary THA using the DAA
compared with those who underwent THA using the posterior approach, with a mean±SD length of stay of
70±3.3 hours in the DAA group and 97±5.5 hours in the lateral approach group (p<0.001)(17)
Retrospective chart
review (USA)
N=200; patients who underwent THA
using either the DAA (n=100) or the
posterior approach (n=100) with a
CORAIL stem and a PINNACLE cup
• In a retrospective review of patients who underwent THA using either the DAA as part of the surgeon’s learning
curve, the DAA following the initial learning curve, or the posterior approach, the mean length of stay was
significantly lower in DAA following the initial learning curve group (2.7 days) compared with the posterior
approach group (3.9 days) (p<0.0001). The mean length of stay was 2.9 days in the DAA during the surgeon’s
learning curve group(18)
Retrospective
review (USA)
N=150; patients who underwent THA
using either the DAA (n=50 during the
surgeon’s learning curve and n=50
subsequent cases), or posterior
approach (n=50)
• In a prospective analysis in patients who underwent THA using either the Hueter, Moor, or Gibson’s approach,
the mean length of stay was 8.91 days in the Hueter approach group, 13.52 days in the Moor approach group,
and 9.87 days in the Gibson approach group(12)
Prospective
analysis (Bosnia
and Herzegovina)
N=126; patients who underwent primary
THA using the Hueter (most medial
[n=34]), Moor (n=56), or Gibson’s
posterolateral (n=46) approach
• The mean±SD length of stay was 3.9±1.1 days in patients who underwent primary THA using the anterior
approach compared with 3.3±1.4 days in patients who underwent THA using the posterior approach (p=0.1)(13)
Prospective
analysis (USA)
N=57; patients with osteoarthritis who
underwent primary THA using the DAA
(n=29) or the posterior approach (n=28)
• In a retrospective analysis comparing patients who underwent THA using one of two minimally invasive
approaches, the DAA was associated mean±SD length of stay of 22.2±1.4 and the mini-posterior approach
was associated with a mean length of stay of 30.4±1.2 days (p=0.003)(14)
Retrospective
analysis (Japan)
N=182 (195 hips); patients with a primary
diagnosis of secondary osteoarthritis
who underwent THA using either the
DAA (n= 99 hips) or the mini-posterior
approach (n=96 hips)
Length of stay is similar or reduced with DAA compared lateral and posterior
approaches (4)
25
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach ctd.
• The mean length of stay associated with THA using either the DAA or the mini-posterior approach was 2.2 days
(p>0.2 between groups)(54)
Prospective
analysis (USA)
N=222 (hips); patients who underwent
using either the DAA (126 hips) or the
mini-posterior approach (96 hips)
• In a prospective comparison between patients who underwent THA using either the DAA or the posterior
approach, there was no significant difference between groups in terms of the mean length of stay (p=0.1).
The mean length of stay was 3.05 days in the DAA group and 3.2 days in the posterior approach group(16)
Prospective
comparative
study (USA)
N=120; patients with unilateral
osteoarthritis of the hip who
underwent primary THA using the
DAA (using a standard operating table
and a table-mounted femoral elevator)
(n=60) or the posterior approach
(n=60)
Length of stay is similar or reduced with DAA compared with lateral and posterior
approaches (5)
26
Length of stay is generally 3-5 days, with times as low as 1.7 days reported (1)
Supporting evidence Study details and patient population
Non-comparative evidence for DAA
• In a retrospective analysis of patients who underwent primary THA using the single incision anterior approach,
the mean±SD length of stay was 3.6±2.4 days(44)
Retrospective
observational study
(USA)
N=1,152; patients who underwent
primary THA using the single incision
anterior approach
• In a prospective analysis of 100 primary THAs using the Smith-Peterson DAA with a HANA traction table, the
mean (range) length of stay was 2.4 (1-5) days(26)
Prospective review
(USA)
N=100; consecutive patients who
underwent THA using the Smith-
Peterson DAA
• In a retrospective analysis of 906 patients who underwent THA using the anterior supine intermuscular approach,
the mean (range) length of stay was 1.7 (1-12) days(27)
Retrospective
analysis (country not
reported)
N=906; patients who underwent
primary or revision THA using the
anterior supine intermuscular
approach
• In a retrospective analysis of 824 patients who underwent THA using the anterior supine intermuscular approach,
the mean (range) length of stay was 1.7 (1-12) days(28)
Retrospective
analysis (USA)
N=824; patients who underwent THA
using the anterior supine
intermuscular approach
• In a prospective analysis of 500 patients who underwent primary THA using the Smith-Peterson DAA with
a traction table (ProFX or HANA), the median length of stay was 3 days(29)
Prospective
analysis (USA)
N=500; patients who underwent
primary THA using the Smith-
Peterson DAA with a ProFX or a
HANA traction table
• In a retrospective analysis of patients who underwent bilateral THA using the anterior approach with a
Judet or ProFX table, the mean (range) length of stay was 4 (2-14) days(36)
Prospective
analysis (USA)
N=147; patients who underwent
simultaneous bilateral THA using
the anterior approach with a Judet
or ProFX table
27
Supporting evidence Study details and patient population
Non-comparative evidence for DAA ctd.
• In a retrospective analysis of patients who underwent primary THA using the single-incision anterior
approach with a Judet or ProFX table, the mean length of stay was 3 days in those undergoing unilateral
THA and 5 days in those undergoing bilateral THA(37)
Retrospective
analysis (USA)
N=437; patients who underwent
primary THA using the single-
incision anterior approach with a
Judet or ProFX table
• The median (range) length of stay was 4 (2-46) days in patients who underwent primary THA using the
anterior approach(38)
Retrospective
analysis (USA)
N=465; patients who underwent
primary THA using the anterior
approach with a Judet or ProFX
table
• The mean length of stay in patients who underwent THA using the anterior approach was 2.56 days(40) Prospective analysis
(USA)
N=356; patients who underwent
primary THA using the anterior
approach
• The mean length of stay in patients who underwent THA using the DAA was 2.3 days(42) Retrospective
analysis (USA)
N=668; patients who underwent THA
using the DAA
• The mean (range) length of stay in patients who underwent primary THA using the anterior approach with
an OSI Profix table was 3.2 (1-18) days(49)
Retrospective
analysis (USA)
N=231 (247 hips); patients who
underwent primary THA using the
anterior approach with an OSI
Profix table
Length of stay is generally 3-5 days, with times as low as 1.7 days reported (2)
28
Contradictory evidence Study details and patient population
Non-comparative evidence
• In a retrospective review of primary THAs conducted using the DAA, the mean±SD hospital stay was
6.4±1.6 days(55)
Retrospective review
(Belgium)
N=300; primary THAs using a DAA
with a positioning table
• In a retrospective analysis of 100 patients who underwent primary THA using the DAA with a leg-positioner Rotex
table, the mean hospital stay was 8 days(31)
Retrospective
analysis (country not
reported)
N=100; patients (main diagnosis was
osteoarthritis) who underwent primary
THA using the DAA with a leg-
positioner Rotex table
• In a retrospective analysis of 903 patients who underwent THA using the anterior approach, the mean length of
stay was 8.3 days, including a pre-operative evaluation day(32)
Retrospective
analysis (USA)
N=903; patients who underwent
primary or revision THA using the
anterior approach
• In a RCT including patients who underwent THA using the DAA, the mean±SD (range) hospital stay was
5.4±1.0 (4-7) days in the no drain group, 6.6±1.0 (5-9) days in the closed suction drain group, and
6.7±1.4 (5-9) days in the retransfusion system group(47)
RCT (Switzerland) N=120; patients with osteoarthritis who
underwent THA using the DAA with an
extension-distraction table (AMIS
mobile leg positioner) and either no
drain (n=40), a closed suction 3.5 mm
drain connected to a vacuumed
(−900 mbar) drainage bottle (n=40), or an ABTrans autologous retransfusion
system (n=40)
• In a retrospective analysis of patients who underwent THA using the anterior approach, the mean hospital stay
was 12.8 days for unilateral procedures and 22.3 days for sequential procedures (usually performed 7-10 days
apart)(35)
Retrospective
analysis (USA)
N=85; patients who underwent primary
or revision THA using the anterior
approach
Contradictory evidence: Length of stay is generally 3-5 days, with times as low as
1.7 days reported
29
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a retrospective review of patients who underwent THA using either the DAA as part of the surgeon’s learning
curve, the DAA following the initial learning curve, or the posterior approach, the mean length of stay was
significantly lower in DAA following the initial learning curve group (2.7 days) compared with the posterior
approach group (3.9 days) (p<0.0001). The mean length of stay was 2.9 days in the DAA during the surgeon’s
learning curve group(18)
Retrospective
review (USA)
N=150; patients who underwent THA
using either the DAA (n=50 during the
surgeon’s learning curve and n=50
subsequent cases), or posterior
approach (n=50)
Length of stay decreases with surgeon experience of DAA
30
In the European Health Care Systems length of stay is reduced with DAA compared with the lateral approach
Length of stay is similar or reduced with DAA compared with the posterior approach
Length of stay is generally 3-5 days, with times as low as 1.7 days reported
Length of stay decreases with surgeon experience of DAA
Evidence indicates that length of stay can be reduced with DAA compared
with lateral and posterior approaches, and decreases with surgeon
experience of DAA
Value theme 2: Patient value
• Post-operative outcomes
Comparative studies reporting evidence in
favour of DAA are outlined in green
Comparative studies reporting neutral
evidence for DAA are outlined in orange
Non-comparative studies are outlined in dark
blue
32
Patients show greater improvements in Harris hip scores and WOMAC
scores with DAA compared with other widely-used THA approaches
33
Patients show greater improvements in HHS (from pre-operative HHS) with DAA
compared with lateral or posterior approaches (1)
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach
• In a retrospective review of patients who underwent THA and were prospectively entered into a clinical database,
the mean HHS was similar between groups at baseline (50 in both groups). At 6 weeks, the mean HHS was
significantly higher in the anterior supine intermuscular approach group that the direct lateral approach group (80
vs 75; p=0.0000)(8)
Retrospective
review (country not
reported)
N=630; patients (main diagnosis of
osteoarthritis) who underwent primary
THA using the anterior supine
intermuscular approach (n=258) or the
direct lateral approach (n=372)
• In a prospective cohort study of patients who underwent primary THA, the minimally invasive approach
was associated with significantly lower mean (range) HHS than the standard lateral transgluteal
approach at 6 weeks (83 [42-100] vs 77 [46-100]; p=0.003), 12 weeks (95 [57-100] vs 91 [44-100]; p=0.009),
and 1 year (99 [73-100] vs 96 [57-100]; p=0.005). At 2 years there was no significant difference between
the minimally invasive approach group and the standard lateral transgluteal approach group in terms of
the mean (range) HHS (99 [56-100] vs 99 [34-100]; p=0.509)(20)
Prospective
cohort study
(Switzerland)
N=255; patients undergoing elective
primary THA using the minimally
invasive anterior approach with a
standard trauma table (n=113) or the
standard lateral transgluteal
approach (n=142)
• In a prospective analysis comparing patients who underwent THA using either the anterior supine intermuscular
approach or the modified Hardinge approach, the anterior supine intermuscular approach was associated with a
significantly higher mean HHS at 6 weeks compared with the modified Hardinge approach (81 vs 75;
p<0.0001)(21)
Prospective
analysis (USA)
N=259; patients who underwent primary
THA using either the anterior supine
intermuscular approach (n=182) or the
modified Hardinge approach (n=77)
• In a prospective analysis, the HHS at follow-up was significantly better in the DAA group compared with the
modified Hardinge approach group (92.2±11.9 vs 97.2±4.5; p=0.04)(56)
Prospective
analysis (country
not reported)
N=69; patients with osteoarthritis who
underwent THA using either the DAA
(n=30) or the modified Hardinge
approach (n=39)
34
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach ctd.
• In a RCT comparing patients who underwent THA using the DAA or the direct lateral approach, the mean HHS at
6 months was 94.6 in the DAA group and 88.6 in the direct lateral approach group (p=0.1)(9)
RCT (USA) N=79; patients who underwent THA
using either the DAA (n=43) or the
direct lateral approach (n=36)
• In a RCT comparing patients who underwent primary THA using a DAA or the direct lateral approach, mean
(range) HHS for DAA vs direct lateral approach were: 51.86 (34-65.5) vs 54.95 (41.5-63.6) (p=0.06) at baseline,
93.64 (77.1-100) vs 88.8 (65-99.7) (p=0.03) at 6 weeks, and 97.34 (93.0-99.7) vs 97.55 (93.0-99.7) (p=0.72) at
2 years(10)
RCT (USA) N=100; patients with a diagnosis of
arthritis who underwent primary THA
using either single-incision Smith-
Peterson DAA (n=50) or the direct
lateral approach (n=50)
• In a prospective analysis, the mean HHS was significantly higher in the DAA group compared with the lateral
transgluteal approach group at 2 months (80.2 vs 69.4; p<0.01) and non-significantly higher in the DAA group
compared with the lateral transgluteal approach group at 4 months (92.4 vs 88.1; p=NS)(11)
Prospective
analysis (Croatia)
N=70; patients who underwent THA
using either the DAA with a standard
orthopaedic table with a leg holder
(n=35) or the lateral transgluteal
approach (n=35)
• In a prospective analysis, mean HHS for the minimally invasive anterior approach vs the direct lateral approach
were: 43.1 vs 43 at baseline, 68.7 vs 58.2 at 2 weeks, 85.3 vs 81.5 at 6 weeks, 91.9 vs 90.2 at 3 months, and
96.7 vs 93.9 at 6 months(57)
Prospective
analysis (country
not reported)
N=60; patients who underwent THA
using the minimally invasive anterior
approach (n=30) or the direct lateral
approach (n=30)
Patients show greater improvements in HHS (from pre-operative HHS) with DAA
compared with lateral or posterior approaches (2)
35
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a RCT comparing THA using the DAA with THA using the posterolateral approach, the HHS was higher in the
DAA group than the posterolateral group, 1 month postoperatively (p<0.03)(23)
RCT (USA) N=88; patients who underwent THA
(main diagnosis was osteoarthritis)
using either the DAA (n=43) or the
posterolateral approach (n=45)
• In a RCT comparing THA using the DAA with THA using the posterolateral approach, the mean±SD HHS
for the DAA group vs the posterolateral group was: 57.6±10.2 vs 55.1±9.1 (p=0.2464) at baseline,
89.5±8.1 vs 81.4±9.8 (p=0.0001) at 6 weeks, 91.2±9.7 vs 91.4±9.7 (p=0.9317) at 3 months, 95.8±7.8 vs
95.9±6.8 (p=0.9680) at 6 months, and 97.5±5.7 vs 97.3±5.5 (p=0.8700) at 12 months(24)
RCT (USA) N=87; patients with non-inflammatory
degenerative joint disease who
underwent primary THA (with a
CORAIL stem and PINNACLE cup)
using the DAA with a modern
fracture table and a C-arm (n=43) or
posterolateral approach (n=44)
• In a RCT comparing patients who underwent THA using the DAA or the mini-incision posterior approach, 1-year
HHS function scores trended towards significance favouring the DAA (p=0.07)(58)
RCT (USA) N=54; patients who underwent THA
using the DAA or the mini-incision
posterior approach
• In a prospective analysis of patients who underwent THA using the DAA or the mini-posterior approach, the HHA
was higher in the DAA group compared with the mini-posterior approach group at 8 weeks (95 and 89,
respectively)(54)
Prospective
analysis (USA)
N=222 (hips); patients who underwent
using either the DAA (126 hips) or the
mini-posterior approach (96 hips)
• In a prospective comparison between patients who underwent THA using either the DAA or the posterior
approach, mean±SD HHS for DAA vs posterior approach were: 49.4±7.5 vs 46.6±11.5 (p=0.17) at
baseline, 69±13 vs 64±9.4 (p=0.09) at 2 weeks, 83±12 vs 80±11 (p=0.13) at 6 weeks, 89±10 vs 88±10
(p=0.29) at 12 weeks, and 89±11 vs 91±10 (p=0.59) at 1 year(16)
Prospective
comparative study
(USA)
N=120; patients with unilateral
osteoarthritis of the hip who
underwent primary THA using the
DAA (using a standard operating
table and a table-mounted femoral
elevator) (n=60) or the posterior
approach (n=60)
Patients show greater improvements in HHS (from pre-operative HHS) with DAA
compared with lateral or posterior approaches (3)
36
Patients report significantly better post-operative WOMAC scores at 6 weeks with
DAA compared with the lateral approach
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach
• In a RCT comparing patients who underwent primary THA using a DAA or the direct lateral approach, mean
(range) WOMAC scores for DAA vs direct lateral approach were: 8.68 (6-12) vs 8.33 (6-11) (p=0.29) at baseline,
4.40 (0-19) vs 9.70 (0-40) (p=0) at 6 weeks, and 2.24 (0-8) vs 1.90 (0-8) (p=0.6) at 2 years(10)
RCT (USA) N=100; patients with a diagnosis of
arthritis who underwent primary THA
using either single-incision Smith-
Peterson DAA (n=50) or the direct
lateral approach (n=50)
• In a RCT comparing patients who underwent THA using the DAA or the direct lateral approach, the mean
WOMAC score at 6 months was 4.1 in the DAA group and 11.1 in the direct lateral approach group (p=0.1)(9)
RCT (USA) N=79; patients who underwent THA
using either the DAA (n=43) or the
direct lateral approach (n=36)
37
Patients report similar post-operative WOMAC scores with DAA compared with
anterolateral and posterior approaches
Supporting evidence Study details and patient population
Evidence comparing DAA with the anterolateral approach
• In a RCT comparing patients who underwent THA using either the DAA or the anterolateral approach, there were
no significant differences between groups in terms of median WOMAC scores (including pain, stiffness and
function scores) at baseline, 6 weeks, and 12 weeks(6)
RCT (Austria) N=33; patients who underwent primary
THA using either the DAA (n=16) or the
anterolateral approach (n=17)
Evidence comparing DAA with the posterior approach
• In a RCT comparing patients who underwent THA using the DAA or the mini-incision posterior approach, 3-week
WOMAC scores trended towards significance favouring the DAA (p=0.08)(58)
RCT (USA) N=54; patients who underwent THA
using the DAA or the mini-incision
posterior approach
38
Additional publications reporting HHS and WOMAC scores for DAA
Supporting evidence Study details and patient population
Evidence comparing DAA with non-DAA approaches (not reported)
• In a prospective analysis, patients who underwent THA using the DAA had significantly better HHS at 6 weeks
than patients who underwent THA using a non-DAA (p<0.0001)(59)
Prospective
analysis (country
not reported)
N=370; patients who underwent THA
using either the DAA (n=185) or a non-
DAA (n=185)
• In a prospective analysis of 100 patients who underwent THA using the anterior supine intermuscular approach,
the mean HHS score was 44 at baseline and 80 at 2-year follow-up. The results of historical data (from the same
surgeon) for patients who underwent THA using a standard approach were reported to be similar(60)
Prospective
analysis (USA)
N=100; patients who underwent THA
using the anterior supine intermuscular
approach (compared with historical data
for patients who underwent THA using a
standard approach [n=not reported])
Non-comparative evidence for DAA
• In a retrospective analysis of patients who underwent THA using the DAA, the mean±SD HSS improved
significantly from 43.6±12 at baseline to 88.2±14 at 35 months (p<0.01). At 35-month follow-up, 66.3% of
patients had excellent score, 18.9% had good scores, 9.5% had fair scores, and 5.3% had poor scores(61)
Retrospective
analysis (Germany)
N=107; patients who underwent THA
using the DAA with head sizes ≥36 mm
• In a retrospective analysis of 1,152 patients who underwent primary THA using the single incision anterior
approach, mean±SD pain scores were: 75.11±19.820 at baseline, 96.62±3.114 at 3 months, 90.44±12.177 at
6 months, 91.31±12.989 at 1 year, 93.07±8.354 at 2 years, and 93.31±1.926 at 3 years. Mean±SD function
scores were: 45.27±12.112 at baseline, 88.14±9.888 at 3 months, 83.40±15.268 at 6 months, 83.43±14.737
at 1 year, 82.02±13.406 at 2 years, and 77.33±6.477 at 3 years(44)
Retrospective
observational study
(USA)
N=1,152; patients who underwent
primary THA using the single incision
anterior approach
39
Patients show significant or greater improvements in HHS (from pre-operative HHS) with DAA compared with lateral or posterior approaches
Patients report significantly better post-operative WOMAC scores at 6 weeks with DAA compared with the lateral approach
Patients report better WOMAC with DAA compared with a posterior approach
Patients report similar WOMAC scores with DAA compared with anterolateral approaches
Patients show greater improvements in Harris hip scores and WOMAC
scores with DAA compared with other widely-used THA approaches
40
Patients generally show better post-operative walking ability with DAA
compared with anterolateral, lateral, or posterior approaches
41
Patients generally show better post-operative walking ability with DAA compared
with compared with anterolateral, lateral, and posterior approaches (1) Supporting evidence Study details and patient population
Evidence comparing DAA with the anterolateral approach
• In a RCT comparing patients who underwent THA using either the DAA or the anterolateral approach, there was a
significant increase in median (IQR) 9 m walkway walking speed in the DAA group at 12 weeks post-operatively
(74.80 [61.88-87.25] pre-operatively vs 93.45 [76.25-109.50] at 12 weeks; p=0.003). This increase was not significant
in the anterolateral approach group (79.00 [69.50-106.00] pre-operatively vs 87.00 [83.70-90.50] at 12 weeks;
p=0.319). There was also a significant increase in median cadence (steps/minute) from pre-operation to 12 weeks in
the DAA group (p=0.005) but not in the anterolateral approach group (p=0.335)(6)
RCT (Austria) N=33; patients who underwent primary
THA using either the DAA (n=16) or the
anterolateral approach (n=17)
• In a prospective analysis, mean±SD self-selected velocities (m/minute) at 6 weeks and 3 months, respectively, were
62.30±6.60 and 71.50±7.90 in the anterolateral group, 54.60±9.80 and 63.80±10.80 in the anterior group,
61.40±13.00 and 69.10±11.90 in the posterior standard group, and 66.50±13.50 and 69.20±11.10 in the posterior
minimally invasive group. Mean±SD cadences (steps/minute) at 6 weeks and 3 months, respectively, were
99.00±16.00 and 112.00±12.00 in the anterolateral group, 100.0±14.00 and 108.00±11.00 in the anterior group,
106.00±20.00 and 116.00±14.00 in the posterior standard group, and 108.00±12.00 and 114.00±10.00 in the
posterior minimally invasive group(62)
Prospective
analysis
(country not
reported)
N=69; patients who underwent THA using
either the anterolateral minimally invasive
surgery approach (n=11), the anterior
minimally invasive surgery approach
(n=10), the posterior standard approach
(n=18), or the posterior minimally invasive
approach (n=30)
Evidence comparing DAA with the lateral approach
• In a prospective analysis comparing patients who underwent THA using either the DAA or the lateral
transgluteal approach, the mean±SD time taken to be able to walk 150 feet (46 m) was 1.87±0.68 days in the
DAA group and 2.42±0.73 days in the lateral transgluteal approach group (p=0.001). At 2 days post-
operatively, 50 patients (83%) in the DAA group and 28 patients (47%) in the posterior approach group could
walk 150 feet(16)
Prospective
analysis
(Croatia)
N=70; patients who underwent THA
using either the DAA with a standard
orthopaedic table with a leg holder
(n=35) or the lateral transgluteal
approach (n=35)
42
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a RCT comparing THA using the DAA with THA using the posterolateral approach, patients in the DAA
group walked further post-operatively than patients in the posterolateral approach group on the day of
surgery (mean±SD: 44.6±28.3 m vs 17.7±23.1 m; p=0.0003), on the first day post-operatively (mean±SD:
173.6±83.8 m vs 121.1±89.8 m; p=0.0062), and on the second day post-operatively (mean±SD:
271.7±88.5 m vs 162.7±80.5 m; p=0.0030). Significantly more patients in the DAA group were walking
unlimited and using stairs normally at 6 weeks post-operatively than in the posterolateral approach group
(p=0.0011)(24)
RCT (USA) N=87; patients with non-inflammatory
degenerative joint disease who
underwent primary THA (with a CORAIL
stem and PINNACLE cup) using the
DAA with a modern fracture table and a
C-arm (n=43) or posterolateral
approach (n=44)
• In a retrospective analysis comparing patients who underwent THA using the DAA or mini-posterior approach,
mean±SE pre-operative 50 m walking time was similar between groups (69.0±5.5 vs 68.7±7.8 seconds,
respectively; p=0.523). At 3 weeks post-operatively, the DAA was associated with a significantly lower mean±SE
50 m walking time compared with the mini-posterior approach (52.3±40.0 vs 74.5±6.3 seconds; p=0.017)(14)
Retrospective
analysis
(Japan)
N=182 (195 hips); patients with a primary
diagnosis of secondary osteoarthritis who
underwent THA using either the DAA (n=
99 hips) or the mini-posterior approach
(n=96 hips)
• In a retrospective chart review of distance walked at physical therapy sessions, in physiotherapy sessions 3 and 4
(when the majority of patients cleared discharge requirements), patients in the DAA group walked significantly further
(mean±SD: 176±12 feet and 182±20 feet in sessions 3 and 4, respectively) compared with patients in the posterior
approach group (mean±SD: 128±12 feet and 117±15 feet in sessions 3 and 4, respectively) (p<0.05). No
significant difference was reported between groups at physiotherapy sessions 1, 2, 5, 6, and 7-12(17)
Retrospective
chart review
(USA)
N=200; patients who underwent THA
using either the DAA (n=100) or the
posterior approach (n=100) with a
CORAIL stem and a PINNACLE cup
Patients generally show better post-operative walking ability with DAA compared
with compared with anterolateral, lateral, and posterior approaches (2)
43
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach ctd.
• In a prospective analysis of patients who underwent THA using the DAA or the mini-posterior approach, there
was no difference in the maximum feet walked in hospital (p>0.2)(54)
Prospective
analysis (USA)
N=222 (hips); patients who underwent
using either the DAA (126 hips) or the
mini-posterior approach (96 hips)
• In a RCT, walking speed increased significantly during the follow-up period in both the minimally invasive surgery
anterior approach group and the conventional posterior approach group (p<0.001 for 6 weeks-3 months,
3-6 months, and 6 weeks-6 months). There was no significant difference in walking speed between the minimally
invasive surgery anterior approach group and the conventional posterior approach group (p=0.79). Cadence was
also comparable between the 2 groups (p=0.06)(63)
RCT
(The Netherlands)
N=105; patients who underwent primary
THA using either the computer navigate
minimally invasive surgery anterior
approach (n=35), the conventional
posterolateral approach (n=40), or
healthy controls (n=30)
• In a prospective analysis, mean±SD self-selected velocities (m/minute) at 6 weeks and 3 months, respectively,
were 62.30±6.60 and 71.50±7.90 in the anterolateral group, 54.60±9.80 and 63.80±10.80 in the anterior
group, 61.40±13.00 and 69.10±11.90 in the posterior standard group, and 66.50±13.50 and 69.20±11.10 in
the posterior minimally invasive group. Mean±SD cadences (steps/minute) at 6 weeks and 3 months,
respectively, were 99.00±16.00 and 112.00±12.00 in the anterolateral group, 100.0±14.00 and 108.00±11.00
in the anterior group, 106.00±20.00 and 116.00±14.00 in the posterior standard group, and 108.00±12.00 and
114.00±10.00 in the posterior minimally invasive group(62)
Prospective
analysis (country
not reported)
N=68; patients who underwent THA
using either the anterolateral minimally
invasive surgery approach (n=11), the
anterior minimally invasive surgery
approach (n=10) the posterior standard
approach (n=18), or the posterior
minimally invasive approach (n=30)
Patients generally show better post-operative walking ability with DAA compared
with compared with anterolateral, lateral, and posterior approaches (3)
44
Patients may discard assistive walking devices sooner with DAA compared with
the posterior approach
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a RCT comparing patients who underwent THA using the DAA or the mini-incision posterior approach, the time
to discard assistive device was 22.8 days in the DAA group and 35.1 days in the posterior approach group
(p=0.04)(58)
RCT (USA) N=370; patients who underwent THA
using the DAA (n=185) or the mini-
incision posterior approach (n=185)
• In a prospective comparison between patients who underwent THA using either the DAA or the posterior
approach, the mean±SD time for which patients used walkers/crutches was 14±8 days in the DAA
group and 14±9 days in the posterior approach group (p=0.76). The mean±SD time for which patients
used a cane was 30±16 days in the DAA group and 31±19 days in the posterior approach group
(p=0.72)(16)
Prospective
comparative study
(USA)
N=120; patients with unilateral
osteoarthritis of the hip who
underwent primary THA using the
DAA (using a standard operating
table and a table-mounted femoral
elevator) (n=60) or the posterior
approach (n=60)
45
Patients may discard assistive walking devices sooner with DAA compared with the posterior approach
Patients generally show better post-operative walking ability with DAA
compared with anterolateral, lateral, or posterior approaches
46
Compared with other THA approaches, DAA may reduce post-operative
pain
47
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a retrospective review of patients who underwent THA using either the DAA as part of the surgeon’s learning
curve, the DAA following the initial learning curve (DAA group), or the posterior approach, pre-operative
mean±SD VAS scores were similar between groups (8.2±1.9, 8.0±1.5, and 7.6±2.1, respectively). At 2 weeks
and 6 weeks, the DAA group had lower mean±SD VAS scores (significant at 2 weeks) than the posterior
approach group (2.2 [1.9] vs 5.2 [2.5]; p<0.0001 and 1.4 [2.6] vs 2.6 [2.7]; p=0.2510). In the DAA learning curve
group, the mean±SD VAS score was 2.7 (2.9) at 2 weeks and 2.2 (2.8) at 6 weeks(18)
Retrospective review
(USA); pain reported
as mean VAS score
N=150; patients who underwent THA
using either the DAA (n=50 during the
surgeon’s learning curve and n=50
subsequent cases), the posterior
approach (n=50)
• In a RCT comparing THA using the DAA with THA using the posterior approach, pain medication was
significantly lower in the DAA group compared with the posterior groups during hospital stay (p<0.05)(23)
RCT (USA) N=88; patients who underwent THA
(main diagnosis was osteoarthritis)
using either the DAA (n=43) or the
posterolateral approach (n=45)
• In a RCT comparing THA using the DAA with THA using the posterolateral approach, there were no
significant differences between treatment groups in terms of HHS and VAS pain scores at 6 weeks, 3
months, 6 months, or 12 months. However, the VAS pain score was significantly lower in the DAA group
vs the posterolateral approach group on the first day after surgery (p=0.0472)(24)
RCT (USA) N=87; patients with non-
inflammatory degenerative joint
disease who underwent primary
THA (with a CORAIL stem and
PINNACLE cup) using the DAA with
a modern fracture table and a C-arm
(n=43) or posterolateral approach
(n=44)
• In a prospective analysis comparing THA using the DAA with THA using the posterior approach, groin
pain was reported in 4 patients in the DAA group and 2 patients in the posterior group. The mean VAS
score at 48 hours post-operatively was 3.3 in the DAA group and 3.5 in the posterior approach group
(p=0.52)(16)
Prospective
comparative study
(USA); pain
reported as mean
VAS score
N=120; patients with unilateral
osteoarthritis of the hip who
underwent primary THA using the
DAA (using a standard operating
table and a table-mounted femoral
elevator) (n=60) or the posterior
approach (n=60)
Patients may have reduced post-operative pain scores with DAA vs the posterior
approach
48
Contradictory evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• DAA was associated with a significantly higher maximum VAS pain than the mini-posterior approach (5.3±2 vs
3.8±2; p<0.0001)(54)
Prospective analysis
(USA)
N=222 (hips); patients who underwent
using either the DAA (126 hips) or the
mini-posterior approach (96 hips)
Contradictory evidence: Patients may have reduced post-operative pain scores
with DAA vs the posterior approach
49
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach
• In a prospective cohort study of patients who underwent primary THA, the minimally invasive approach
was associated with significantly lower median (range) VAS pain scores than the standard lateral
transgluteal approach at 6 weeks (1.0 [1-8] vs 1.5 [0-8]; p=0.003), 12 weeks (0.0 [0-8] vs 1.0 [0-8]; p=0.010),
and 1 year (0.0 [0-8.8] vs 0.0 [0-7.2]; p=0.040). At 2 years there was no significant difference between the
minimally invasive approach group and the standard lateral transgluteal approach group in terms of the
median (range) VAS score (0.0 [0-5] vs 0.0 [0-10]; p=0.403)(20)
Prospective cohort
study (Switzerland);
pain reported as
median VAS score
N=255; patients undergoing elective
primary THA using the minimally
invasive anterior approach with a
standard trauma table (n=113) or
the standard lateral transgluteal
approach (n=142)
• In a study that used patient questionnaires to assess pain experienced during hospitalisation, overall pain
remembered by patient and pain during movement were significantly lower in DAA group compared with the
modified Hardinge approach group (2.4 [SD 1.2] vs 1.9 [0.9]; p=0.04, and 2.6 [2.3] vs 1.7 [2]; p=0.05)(56)
Prospective analysis
(country not reported)
N=69; patients with osteoarthritis who
underwent THA using either the DAA
(n=30) or the modified Hardinge
approach (n=39)
• In a retrospective analysis, the mean NRS score on the first post-operative day was 1.4 in patients who
underwent THA using the DAA and 2.5 in patients who underwent THA using the lateral approach(19)
Retrospective
analysis (Italy); pain
reported as NRS
score
N=419; patients who underwent
primary THA (main diagnosis was
coxarthrosis) using either the DAA
(n=221) or lateral approach (n=198)
• In a prospective analysis comparing patients who underwent THA using either the DAA or the lateral
transgluteal approach, 1 patient reported knee pain in the DAA group and pain was not reported in the
lateral transgluteal group(11)
Prospective
analysis (Croatia)
N=70; patients who underwent THA
using either the DAA with a
standard orthopaedic table with a
leg holder (n=35) or the lateral
transgluteal approach (n=35)
Patients may have reduced post-operative pain scores with DAA vs the lateral
approach
50
Contradictory evidence Study details and patient population
Evidence comparing DAA with the lateral approach
• * Patients in the DAA group showed significantly lower pain than the Bauer approach group during physiotherapy
exercise on Day 1 after surgery (p=0.013). However, during the following days, the DAA group had higher mean
pain levels than the Bauer approach group, with statistically significant differences at Days 3 (p=0.013), 6
(p=0.017), 7 (p=0.005), 8 (p=0.002), and 9 (p=0.001)(51)
Retrospective
analysis (Germany)
N=200; patients who underwent THA
using either the modified Smith-
Peterson DAA (n=100) or the Bauer
approach (n=100)
• In a prospective analysis, mean EQ-VAS for the minimally invasive anterior approach vs the direct lateral
approach were: 41.1 vs 55.6 at baseline, 72.5 vs 67.8 at 2 weeks, 85.9 vs 80.6 at 6 weeks, 87.8 vs 84 at
3 months, and 92.4 vs 91.3 at 6 months(57)
Prospective analysis
(country not reported)
N=60; patients who underwent THA
using the minimally invasive anterior
approach (n=30) or the direct lateral
approach (n=30)
Contradictory evidence: Patients may have reduced post-operative pain scores
with DAA vs the lateral approach
This study clearly states that the post-op pain for patients with DAA was lower on day 1 and higher on the following days.
However, the hospital initiated a full weight bearing program with the DAA group vs. 20 kg max. in the control group; which
according to the authors may have been the reason behind this finding (the increase in pain within the DAA group).
51
Supporting evidence Study details and patient population
Evidence comparing DAA with the lateral approach
• In a study that used patient questionnaires to assess pain experienced during hospitalisation, overall pain
remembered by patient and pain during movement were significantly lower in DAA group compared with the
modified Hardinge approach group (2.4 [SD 1.2] vs 1.9 [0.9]; p=0.04, and 2.6 [2.3] vs 1.7 [2]; p=0.05)(56)
Prospective analysis
(country not reported)
N=69; patients with osteoarthritis who
underwent THA using either the DAA
(n=30) or the modified Hardinge
approach (n=39)
• Patients in the DAA group showed significantly lower pain than the Bauer approach group during physiotherapy
exercise on Day 1 after surgery (p=0.013). However, during the following days, the DAA group had higher mean
pain levels that the Bauer approach group, with statistically significant differences at Days 3 (p=0.013), 6
(p=0.017), 7 (p=0.005), 8 (p=0.002), and 9 (p=0.001)(51)
Retrospective
analysis (Germany)
N=200; patients who underwent THA
using either the modified Smith-
Peterson DAA (n=100) or the Bauer
approach (n=100)
With DAA vs the lateral approach, patients report significantly lower pain during
hospitalisation, as well as significantly lower pain on Day 1 after surgery
Although the Goebel et al, 2012 reference supports this value message, it may be considered to be unfavourable for DAA as
higher mean pain levels were reported at subsequent time points. However, this study reports a positive impact of DAA on time
to recovery and length of stay
52
Additional publications reporting pain
Supporting evidence Study details and patient population
Evidence comparing DAA with a non-DAA approach (not reported)
• In a prospective analysis, patients who underwent THA using the DAA had significantly less pain than patients
who underwent THA using a non-DAA (p<0.0001)(59)
Prospective
analysis (country
not reported)
N=370; patients who underwent THA
using either the DAA (n=185) or a non-
DAA (n=185)
Non-comparative evidence for DAA
• In a retrospective analysis of 1,152 patients who underwent primary THA using the single incision anterior
approach, 9 patients (0.8%) reported pain(44)
Retrospective
observational study
(USA)
N=1,152; patients who underwent
primary THA using the single incision
anterior approach
• In a prospective analysis of 100 primary THAs using the Smith-Peterson DAA with a HANA traction table,
4 patients (4%) reported thigh numbness, which was clinically insignificant at the 3 month visit(26)
Prospective
review (USA)
N=100; consecutive patients who
underwent THA using the Smith-
Peterson DAA
• In a RCT including patients who underwent THA using the DAA, mean±SD VAS scores on Day 1 post-operation
were 2.1±1.7, 1.4±1.9, and 1.2±1.59 in the no drain, closed suction drain, and retransfusion system groups,
respectively. These scores were reduced on Day 2 (1.4±2.3, 1±1.5, and 0.7±1.2 in the no drain, closed suction
drain, and retransfusion system groups, respectively) and were 0.7±1.2 in all groups on Day 3(47)
RCT (Switzerland);
pain was reported
as mean VAS score
N=120; patients with osteoarthritis who
underwent THA using the DAA with an
extension-distraction table (AMIS mobile
leg positioner) and either no drain
(n=40), a closed suction 3.5 mm drain
connected to a vacuumed (−900 mbar) drainage bottle (n=40), or an ABTrans
autologous retransfusion system (n=40)
53
Evidence shows that patients may have reduced post-operative pain scores with DAA vs the posterior.
With DAA vs the lateral approach, patients report significantly lower pain during hospitalisation.
Compared with other THA approaches, DAA may reduce post-operative
pain
Value theme 3: Long-term value
• Revision rates
Comparative studies reporting evidence in
favour of DAA are outlined in green
Comparative studies reporting neutral
evidence for DAA are outlined in orange
Non-comparative studies are outlined in dark
blue
55
Revision rates for DAA are low and comparable with other widely-used THA
approaches
56
Revision rates for DAA are low and comparable with other widely-used THA
approaches (1)
Supporting evidence Study details and patient population
Evidence comparing DAA with the posterior approach
• In a retrospective comparative study, no revisions were reported in 16 months in patients who underwent
THA using the DAA and 1 revision (0.3%) was reported in 30 months in patients who underwent THA
using the posterior approach. In those patients forming part of the DAA learning curve, 2 revisions were
reported in 22 months(25)
Retrospective
comparative study
(USA)
N=677; patients who underwent
primary THA using the DAA
(n=286), the posterior approach
with a standard operating table and
table-mounted femoral elevator,
and with fluoroscopy (n=293), or
those forming part of the DAA
learning curve (n=96)
Evidence comparing DAA with a standard THA approach (not reported)
• In a prospective analysis of 100 patients who underwent THA using the anterior supine intermuscular approach,
3 revisions (3%) were reported in 2 years. The revision rate reported was similar to the revision rate observed
using historical data (from the same surgeon) for patients who underwent THA using a standard approach(60)
Prospective analysis
(USA)
N=100; patients who underwent THA
using the anterior supine
intermuscular approach (compared
with historical data for patients who
underwent THA using a standard
approach [number not reported])
Non-comparative evidence for DAA
• In a retrospective analysis of 956 primary or revision THAs using the anterior supine intermuscular approach, 16
revisions (1.6% incidence) were reported at 40 months follow-up, including 6 periprosthetic femur fractures,
1 stem subsidence, 2 acetabular failures, 3 dislocations, and 3 infections(53)
Retrospective review
(USA)
N=956; consecutive primary (n=956)
and revision (n=44) THA using the
anterior supine intermuscular
approach
57
Supporting evidence Study details and patient population
Non-comparative evidence for DAA ctd.
• In a retrospective analysis of 906 patients who underwent THA (1,035 THA) using the anterior supine
intermuscular approach, 25 revisions (2.4% incidence of THA revision) were reported at up to 56 months follow-
up(27)
Retrospective
analysis (country not
reported)
N=906; patients who underwent
primary or revision THA using the
anterior supine intermuscular
approach
• In a retrospective analysis of 824 patients who underwent THA (935 THAs) using the anterior supine
intermuscular approach, 21 revisions (2.2% incidence of THA revision) were reported at up to 73 months follow-
up(28)
Retrospective
analysis (USA)
N=824; patients who underwent THA
using the anterior supine
intermuscular approach
• In a retrospective analysis of 709 patients who underwent primary THA using the DAA, 13 revisions (1.8%
incidence of THA revision) were reported in 3.5 years.(64)
Retrospective
analysis (USA)
N=709; patients with arthritis who
underwent primary THA using the DAA
• In a retrospective analysis of 147 patients who underwent bilateral THA using the anterior approach with
a Judet or ProFX table, no revisions were reported at 1 year(36)
Prospective
analysis (USA)
N=147; patients who underwent
simultaneous bilateral THA using
the anterior approach with a Judet
or ProFX table
• In a retrospective analysis of 247 primary THAs using the anterior approach with an OSI Profix table,
3 reoperations (1.2%) and 3 revisions (1.2%) were reported in 8.4 months(49)
Retrospective
analysis (USA)
N=231 (247 hips); patients who
underwent primary THA using the
anterior approach with an OSI
Profix table
Revision rates for DAA are low and comparable with other widely-used THA
approaches (2)
58
Revision rates for DAA are low and comparable with other widely-used THA
approaches
59
Value of CORAIL/PINNACLE
• Overview of evidence
• Value theme 1: Inpatient value
• Value theme 2: Patient value
• Value theme 3: Long-term value
60
Value theme 1: Inpatient value
• Theatre time
• Length of stay
Studies reporting evidence in favour of DAA
are outlined in green. However, all studies
are non-comparative and good outcomes
are defined as per notes section
61
Duration of surgery is within a normal range in patients undergoing THA
with CORAIL/PINNACLE, regardless of surgical approach
Length of hospital stay is within a normal range in patients undergoing THA
with CORAIL/PINNACLE, regardless of surgical approach
62
Duration of surgery is generally 60-90 minutes in patients undergoing THA with
CORAIL/PINNACLE
Supporting evidence Study details and patient population
• In a RCT of patients with a BMI <30 kg/m2 who received unilateral THA with a CORAIL stem and PINNACLE cup
using a transgluteal lateral approach (Bauer [n=42]) or a minimally invasive approach (MicroHip [n=36]), both
THA approaches were associated with acceptable theatre time (mean ± SD: 66±27 minutes using the
transgluteal lateral approach and 55±15 minutes using the minimally invasive approach).(1) Theatre times were
higher but acceptable in patients with a BMI ≥30 kg/m2: 70±28 minutes using the transgluteal lateral approach
(n=41) and 60±9 minutes using the minimally invasive approach (n=15)(65)
Prospective RCT
(Germany);
mean±SD surgery
time reported by BMI
group
N=134; patients undergoing unilateral
THA with a CORAIL stem and a
PINNACLE cup
• In a prospective cohort study, the mean duration of surgery in patients undergoing THA with a CORAIL stem and
a PINNACLE cup was 59 minutes (range: 34-112 minutes)(66)
Prospective, single
centre cohort study
(UK)
N=316; patients undergoing THA with
a CORAIL stem and a PINNACLE cup
63
Evidence Study details and patient population
• The mean operative time in patients undergoing primary THA with either a CORAIL or a different cementless
stem and a PINNACLE cup was 110 minutes (range: 64-183 minutes)(67)
Retrospective
analysis of
prospectively
collected data (UK)
N=54 undergoing primary THA (61
hips) with either a CORAIL or a
different cementless stem and a
PINNACLE cup
Contradictory evidence: Duration of surgery is generally 60-90 minutes in patients
undergoing THA with CORAIL/PINNACLE
64
Supporting evidence Study details and patient population
• In a prospective cohort study, the median post-operative length of stay in patients undergoing THA with a
CORAIL stem and a PINNACLE cup was 3 days (range: 1-49 days)(66)
Prospective, single
centre cohort study
(UK)
N=316 undergoing THA with a
CORAIL stem and a PINNACLE cup
• In a retrospective analysis of prospectively collected data, the mean length of hospital stay in patients undergoing
primary THA with either a CORAIL or a different cementless stem and a PINNACLE cup was 3.85 days (range:
2-13 days). The patient with a 13 day length of stay had a history of chronic obstructive pulmonary disease and
was admitted to the ICU post-operatively due to aspiration pneumonia(67)
Retrospective
analysis of
prospectively
collected data (UK)
N=54 undergoing primary THA (61
hips) with either a CORAIL or a
different cementless stem and a
PINNACLE cup
• In a prospective analysis, the mean length of stay in patients who received THA with a CORAIL stem and a
PINNACLE cup was 1.99 nights (range: 1-19 nights)(68)
Prospective analysis
of patients included in
a short stay THA
programme (England
and Wales)
N=100 who underwent THA with a
CORAIL stem and a PINNACLE cup
Length of hospital stay is generally 3-5 days in patients undergoing THA with
CORAIL/PINNACLE
65
Evidence Study details and patient population
• In patients with a BMI <30 kg/m2 who received unilateral THA with a CORAIL stem and PINNACLE cup using a
transgluteal lateral approach (Bauer [n=42]) or a minimally invasive approach (MicroHip [n=36]), the mean±SD
number of days to discharge was 9±2 days and 8±1 days, respectively.(1) Similarly, in patients with a BMI score
≥30kg/m2, the mean±SD number of days to discharge was 9±2 days in both the transgluteal lateral approach
group (n=41) and the minimally invasive approach group (n=15)(65)
Prospective RCT
(Germany);
mean±SD days to
discharge reported by
BMI group
N=134; patients undergoing unilateral
THA with a CORAIL stem and a
PINNACLE cup
Contradictory evidence: Length of hospital stay is generally 3-5 days in patients
undergoing THA with CORAIL/PINNACLE
66
Duration of surgery is generally 60-90 minutes in patients undergoing THA with CORAIL/PINNACLE
Duration of surgery is within a normal range in patients undergoing THA
with CORAIL/PINNACLE, regardless of surgical approach
Length of hospital stay is generally 3-5 days in patients undergoing THA with CORAIL/PINNACLE
Length of hospital stay is within a normal range in patients undergoing THA
with CORAIL/PINNACLE, regardless of surgical approach
67
Value theme 2: Patient Value
• Post-operative outcomes
Studies reporting evidence in favour of DAA are
outlined in green. However, all studies are non-
comparative. Good outcomes are therefore
defined in the notes section
68
Patients who undergo THA with CORAIL/PINNACLE show significant
improvements from pre-operation in composite scores assessing pain,
function, deformity, stiffness, and range of motion
69
Patients who undergo THA with CORAIL/PINNACLE show dramatic improvements
in HHS from pre-operation to 1 and 2 years post-operatively
Supporting evidence Study details and patient population
• In a prospective cohort study including 28 patients undergoing THA with a CORAIL stem and a PINNACLE cup,
the mean total HHS score (median±SD) improved dramatically, increasing from 35±11 pre-operatively to
91±13 at 1 year post-operatively and 92±14 at 2 years post-operatively (no p-values were reported)(69)
Prospective cohort
study (Australia)
N=28; patients undergoing THA with a
CORAIL stem and a PINNACLE cup
<70%=poor (−), 70-80=fair (0), 80-90=good (+), 90-100=excellent (+)
70
Significant improvements in pre-operative HHS and OHS are observed in patients
who undergo THA with CORAIL/PINNACLE, regardless of BMI (1) Supporting evidence Study details and patient population
Evidence reporting HHS
• In patients with a BMI score <30 kg/m2 who underwent THA with a CORAIL stem and a PINNACLE cup using a
transgluteal lateral approach (Bauer [n=42]) or a minimally invasive approach (MicroHip [n=36]), there were
significant improvements (p<0.001) in the mean HHS from baseline (pre-operation) (48±15 and 46±16,
respectively) to 3 months post-operation (84±18 and 88±16, respectively).(3) Similarly, in patients with a BMI
score ≥30 kg/m2, the mean HHS improved significantly (p<0.001) from baseline to 3 months, increasing from
44±15 to 88±12 in the transgluteal lateral approach group (n=41) and from 46±16 to 88±11 in the minimally
invasive approach group (n=15)(65)
Prospective RCT
(Germany);
mean±SD HHS
reported by BMI
group
N=134; patients undergoing unilateral
THA with a CORAIL stem and a
PINNACLE cup
<70%=poor (−), 70-80=fair (0), 80-90=good (+), 90-100=excellent (+)
Evidence reporting OHS using the current scoring system
• In patients with a BMI score <30 kg/m2 who underwent THA with a CORAIL stem and a PINNACLE cup using a
transgluteal lateral approach (Bauer [n=42]) or a minimally invasive approach (MicroHip [n=36]), there were
significant improvements (p<0.001) in the mean OHS from baseline (pre-operation) (20±8 and 21±8,
respectively) to 3 months post-operation (39±10 and 42±6, respectively).(1) Similarly, in patients with a BMI
score ≥30 kg/m2, the mean OHS improved significantly (p<0.001) from baseline to 3 months , increasing from
19±8 to 18±7 in the transgluteal lateral approach group (n=41) and from 41±6 to 43±5 in the minimally
invasive approach group (n=15)(65)
Prospective RCT
(Germany);
mean±SD OHS
reported by BMI
group
N=134; patients undergoing unilateral
THA with a CORAIL stem and a
PINNACLE cup
• In a prospective RCT in which patients underwent THA using a CORAIL stem (with a ceramic femoral head) and
PINNACLE cup, the mean OHS improved significantly (p-values not reported) from pre-operation to 12 months
post-operation: the mean pre-operative OHS was 18 (range: 4-33) and the mean 12 month post-operative OHS
was 42 (range: 15-48)(70)
Prospective RCT
(New Zealand)
N=41; patients with osteoarthritis
undergoing THA with a CORAIL stem
and a PINNACLE cup randomised to
receive a ceramic femoral head
OHS scores <27=poor (−), 27-33=fair (0), 34-41=good (+), >41=excellent (+)
71
Supporting evidence Study details and patient population
Evidence reporting OHS using a previous scoring system
• In 316 patients who underwent THA with a CORAIL stem and a PINNACLE cup, the mean OHS score decreased
(indicating a reduction in difficulties†) from 49.5 (95% CI: 48.9, 50.1) pre-operatively to 26.5 (95% CI: 25.7, 27.3)
6 weeks post-operatively(66)
Prospective, single
centre cohort study
(UK)
N=316 undergoing THA with a
CORAIL stem and a PINNACLE cup
† This publication reports data using a previous version of the OHS, which is scored on a scale of 12-60 (best to worst)
Significant improvements in pre-operative HHS and OHS are observed in patients
who undergo THA with CORAIL/PINNACLE, regardless of BMI (2)
72
Significant improvements across all domains (pain, stiffness, and physical function) of pre-
operative WOMAC scores are observed in patients who undergo THA with CORAIL/PINNACLE
Supporting evidence Study details and patient population
• In a prospective RCT in which patients underwent THA using a CORAIL stem (with a ceramic femoral head) and
PINNACLE cup, the mean WOMAC improved significantly (p-values not reported) from pre-operation to 12
months post-operation: the mean pre-operative WOMAC was 38 (range: 11-36) and the mean 12 month post-
operative WOMAC was 83 (range: 33-96)(70)
Prospective RCT
(New Zealand)
N=41; patients with osteoarthritis
undergoing THA with a CORAIL stem
and a PINNACLE cup randomised to
receive a ceramic femoral head
• In 316 patients who underwent THA with a CORAIL stem and a PINNACLE cup, there were significant
improvements (p-values not reported) from pre-operation to 6 weeks post-operation in WOMAC across 3
domains:(66)
o For pain, the mean WOMAC was 14.0 (95% CI: 13.6, 14.4) pre-operatively and 4.4 (95% CI: 4.0-4.8) at 6
weeks post-operatively
o For stiffness, the mean WOMAC was 5.7 (95% CI: 5.5, 5.9) pre-operatively and 2.7 (95% CI: 2.5-2.9) at 6
weeks post-operatively
o For physical function, the mean WOMAC was 51.4 (95% CI: 50.4, 52.4) pre-operatively and 23.5 (95% CI:
21.9-25.1) at 6 weeks post-operatively
Prospective, single
centre cohort study
(UK)
N=316; patients undergoing THA with
a CORAIL stem and a PINNACLE cup
† In the Schouten et al, 2012 publication, increased WOMAC indicated an improvement whereas, in the Hunt et al, 2009 publication, higher scores indicated greater impairment
73
Additional publications reporting HHS and OHS
Supporting evidence Study details and patient population
Evidence reporting HHS
• In a retrospective analysis of patients who underwent primary THA, the mean±SD HHS was 95.4±7.1 (95% CI:
96.6, 98) at the latest follow-up (mean, 3.8 years; range, 2.1-5.4 years)(71)
Retrospective
analysis (Austria)
N=60 hips (58 patients); patients who
underwent primary THA with CORAIL
(n=49) or other cementless stems
(n=11) and PINNACLE cups
† <70%=poor (−), 70-80=fair (0), 80-90=good (+), 90-100=excellent (+)
Evidence reporting OHS using the current scoring system
• In patients who were followed and questioned regarding OHS after THA using a CORAIL stem and a PINNACLE
cup, the median OHS reported was 47 (IQR: 41-48) at a median follow-up of 38 months (IQR: 32-53)(72)
Prospective study
(UK)
N=103 identified from a site
arthroplasty database who had
undergone THA using a CORAIL stem
and a PINNACLE cup
† OHS scores <27=poor (−), 27-33=fair (0), 34-41=good (+), >41=excellent (+)
Evidence reporting OHS using a previous scoring system
• In a prospective patient database analysis reporting survival of the stem (CORAIL) and cup (83% PINNACLE) at
3 years following THA, the average 3-year OHS was 12 (indicating the lowest level of difficulty†)(73)
Prospective database
analysis (UK)
N=751; THA cases using a CORAIL
stem (version modified in 2004 with
increased neck taper). A PINNACLE
cup was used in 83% of cases (17%
not reported)
† This publication reports data using a previous version of the OHS, which is scored on a scale of 12-60 (best to worst)
74
Patients who undergo THA with CORAIL/PINNACLE show notable improvements in HHS from pre-operation to 1 and 2 years post-operatively
Significant improvements in pre-operative HHS and OHS are observed in patients who undergo THA with CORAIL/PINNACLE, regardless of BMI
Significant improvements across all domains (pain, stiffness, and physical function) of pre-operative WOMAC scores are observed in patients who undergo THA with CORAIL/PINNACLE
Patients who undergo THA with CORAIL/PINNACLE show significant
improvements from pre-operation in composite scores assessing pain,
function, deformity, stiffness, and range of motion
75
Value theme 3: Long-term value
• Revision rates/survivorship
• Radiographic outcomes
Studies reporting evidence in favour of DAA are
outlined in green. However, all studies are non-
comparative. Good outcomes are therefore
defined in the notes section
76
Long-term outcomes are good with CORAIL/PINNACLE, with low revision
rates and low incidence of stem subsidence and cup migration
77
Cumulative revision rates are low in patients who undergo THA with
CORAIL/PINNACLE and survivorship is generally ≥95% at 10 years (1) Supporting evidence Study details and patient population
Evidence from peer reviewed literature
• In a study conducted to establish revision rate, reoperation rate, patient reported functional outcomes, health
measures, and satisfaction in patients who had undergone THA with a CORAIL stem and PINNACLE cup, one
revision was reported at 98 months, resulting in a survivorship for revision of 99.0% (95% CI: 93.2, 99.9)(72)
Prospective study
(UK)
N=103 identified from a site
arthroplasty database who had
undergone THA using a CORAIL stem
and a PINNACLE cup
• In a prospective patient database analysis reporting survival of the stem (CORAIL) and cup (83% PINNACLE) at
3 years following THA, overall survival was 99.5%. Survival of the stem at 3 years was 99.9%, with 1 case of
periprosthetic fracture following a fall. Survival of the cup at 3 years and was 99.6%(73)
Prospective database
analysis (UK)
N=751 THA cases using the CORAIL
stem (version modified in 2004 with
increased neck taper). PINNACLE cup
was used in 83% of cases (17% not
reported)
• In a retrospective analysis using data reported by the NJR for 35,386 THA procedures using a CORAIL stem and
a PINNACLE cup conducted in patients with a primary diagnosis of osteoarthritis, the overall rate of revision rate
at 5 years was 2.41% (99% CI: 2.02, 2.79). The cumulative revision rate was 1.77% (99% CI: 1.53, 2.01) at 3
years and 0.79% (99% CI: 0.66, 0.93) at 1 year(74)
Retrospective cohort
study (UK)
N=35,386 procedures in patients with
osteoarthritis in the NJR (301 sites)
who underwent THA using a CORAIL
stem and a PINNACLE cup
Guidance from the National Institute of Health and Care Excellence (NICE) states that prostheses for THA should only be
recommended as treatment options if prostheses have rates (or projected rates) of revision ≤5% at 10 years.(3) However, the
available evidence does not always provide 10 year revision rates/survivorship
78
Supporting evidence Study details and patient population
Evidence from registry data
• In 26,938 primary, conventional THA cases using a CORAIL stem and a PINNACLE cup, the Australian
Orthopaedic Association National Joint Replacement Registry reported a cumulative percent revision of 2.5%
(95% CI: 2.3, 2.7) at 3 years, 3.1% (95% CI: 2.9, 3.4) at 5 years, 3.7% (95% CI: 3.3, 4.0) at 7 years, and 5.4%
(95% CI: 4.5, 6.5) at 10 years(75)
Registry report
(Australia)
N=26,938; THA cases using a
CORAIL stem and PINNACLE cup
• In 4,596 primary THA cases using a CORAIL stem and a PINNACLE cup, the New Zealand Joint Registry
reported a revision rate of 0.74 per 100 component years (95% CI: 0.61, 0.88)(76)
Registry report
(New Zealand)
N=4,596; THA cases using a CORAIL
stem and PINNACLE cup
• In 1,988 THA cases using a CORAIL stem and a PINNACLE cup from 2003-2011, the Slovak Arthroplasty
Register reported a revision rate of 0.60(77)
Registry report
(Slovakia)
N=1,988; THA cases using a CORAIL
stem and PINNACLE cup
• In 4,453 THA cases using a CORAIL stem and a PINNACLE cup, the Danish Arthroplasty Register reported
survivorship of 95.6% (95% CI: 94.6-96.6) at 5 years(78)
Registry report
(Denmark)
N=4,453; THA cases using a CORAIL
stem and PINNACLE cup
Cumulative revision rates are low in patients who undergo THA with
CORAIL/PINNACLE and survivorship is generally ≥95% at 10 years (2)
Guidance from the National Institute of Health and Care Excellence (NICE) states that prostheses for THA should only be
recommended as treatment options if prostheses have rates (or projected rates) of revision ≤5% at 10 years.(3) However, the
available evidence does not always provide 10 year revision rates/survivorship
79
Contradictory evidence Study details and patient population
Evidence from registry data
• In 95,702 THA cases using a CORAIL stem and a PINNACLE cup, the National Joint Registry (NJR) of England,
Wales, and Northern Ireland reported a cumulative percentage probability of revision of 2.89% (95% CI: 2.75,
3.03) at 5 years, 4.75% (95% CI: 4.51, 5.00) at 7 years, and 7.94% (95% CI: 7.10, 8.88) at 10 years(79)
Registry report
(England, Wales, and
Northern Ireland)
N=95,702; THA cases using a
CORAIL stem and PINNACLE cup
Contradictory evidence: Cumulative revision rates are low in patients who undergo
THA with CORAIL/PINNACLE and survivorship is generally ≥95% at 10 years
80
Clinically significant stem subsidence (≥3 mm) is not observed in patients who undergo THA using a CORAIL stem
Supporting evidence Study details and patient population
Evidence for stem subsidence
• In 36 patients who underwent elective THA using a CORAIL collarless stem and a PINNACLE cup, mean femoral
stem subsidence at 6-12 months post-operation was 1.57 mm (range: 0-5.5 mm)(80)
Retrospective
analysis (UK)
N=36; patients with osteoarthritis who
underwent THA with a CORAIL stem
and a PINNACLE cup
• In a prospective patient database analysis of 751 THA cases, all using a CORAIL stem and 83% using a
PINNACLE cup, subsidence of the CORAIL stem had occurred in 0.3% of cases at 3 years(73)
Prospective database
analysis (UK)
N=751; THA cases using a CORAIL
stem (version modified in 2004 with
increased neck taper). A PINNACLE
cup was used in 83% of cases (17%
not reported)
• In a prospective cohort study in patients undergoing THA using a CORAIL stem and PINNACLE cup, mean stem
subsidence at 6 years was 0.63 mm (range: −0.33 mm to 3.68 mm). Only 4 stems (of the 27 hips analysed) subsided >0.1 mm between 6 months and 6 years, and 3 stems subsided >0.1 mm between 2 years and 6 years.
For all stems, additional subsidence after 6 months was <0.25 mm. The mean subsidence between 2 and 6
years was therefore 0.03 mm (below the limit measurable using RadioStereometric Analysis)(81)
Prospective cohort
study (Australia)
N=30 (27 analysed); patients with
osteoarthritis undergoing THA with a
CORAIL stem and a PINNACLE cup
81
Few cases of clinically significant cup migration are observed with the PINNACLE
cup and, in cases of early cup migration >1 mm, migration curves generally flatten
down rapidly after 3 months
Supporting evidence Study details and patient population
Evidence for cup migration
• In a retrospective analysis of patients who underwent primary THA, migration curves could be applied for 57 of
60 cases using PINNACLE cups. Within the first 3 months, clinically significant cup migration of >1 mm was
reported in 8 of these 57 cases.(71) The authors reported that further analyses of migration patterns provided
reassurance that these results were not of concern due to the following:(71)
o Migration curves flattened down rapidly after the third postoperative month, indicating that osseointegration
of the porocoat surface of the Pinnacle cup may have occurred
o Of the 8 cups that migrated >1 mm within the first 3 months, 7 reached a plateau phase or a lower, but
nearly curvilinear migration by 12 months
o Only 2 cups of the whole cohort showed constantly increasing, linear migration patterns and were in need of
close clinical and radiological follow-up
Retrospective
analysis (Austria)
N=60 hips (58 patients); patients who
underwent primary THA with CORAIL
(n=49) or a different cementless stem
(n=11) stems and PINNACLE cups
82
Cumulative revision rates are low in patients who undergo THA with CORAIL/PINNACLE and survivorship is generally ≥95% at 10 years
Clinically significant stem subsidence (≥3 mm) is not observed in patients who undergo THA using a CORAIL stem
Few cases of clinically significant cup migration are observed with the PINNACLE
cup and, in cases of early cup migration >1 mm, migration curves generally flatten down rapidly after 3 months
Long-term outcomes are good with CORAIL/PINNACLE, with low revision
rates and low incidence of stem subsidence and cup migration
83
Mean length of stay is significantly lower in patients who undergo THA using DAA with a modern fracture table and C-arm fluoroscopy (2.28 days) vs the posterolateral approach (3.02 days) (p=0.0374)(24)
Length of hospital stay is low or normal in patients who undergo DAA with a traction table (HANA, Judet, or ProFX), with reported median lengths of stay of 2–3 days, and reported mean lengths of stay of 3–3.2 days for unilateral THA and 4–5 days for bilateral THA(29, 36-
38, 49)
In the short term, low revision rates have been reported in patients who undergo THA using DAA with a traction table (Judet, ProFX, or OSI Profix)(36, 49)
Duration of surgery is generally within a normal range of 60–90 in patients undergoing THA using DAA with a traction table (HANA, Rotex, ProFX, or Judet , with theatre times as low as 53 minutes reported (HANA table)(36-38, 26, 29-31)
Value messaging for the traction table and fluoroscopy
84
Appendices for DAA
• Systematic review
methodology
• PRISMA flow diagram for
DAA
85
Systematic review methodology
• Databases (Embase, MEDLINE, the Cochrane Library) were searched on 11th April 2014. Reference lists of included
studies, clinical trial registries, recent 2011-2014 topical conference proceedings, and topical orthopaedic registries
were searched manually
• Two additional publications were later identified in a published systematic review(82) and included
• Patient population included: individuals undergoing THA surgery (primary or revision) using the anterior approach
• Interventions included: the anterior approach with or without using a bespoke surgical table (with or without a C-
arm)
• Comparators included: alternative surgical approaches for THA
• Outcomes included:
o Efficacy/effectiveness: maintaining stability, returning to normal mobility, mobility of limbs, weak/impaired gait,
more rapid recovery, hip function and gait ability, component positioning, cup placement
o Safety and reliability: dislocation rate, cement leakage, leg length discrepancy, infection rate, intraoperative
fracture rate, heterotopic ossification, intraoperative blood loss, post-operative adverse events, muscle damage,
nerve damage, learning curve
o Costs and resource use: length of hospital stay, learning curve, increased patient volume, reduced resource
utilisation (any outcome)
o Quality of life: any patient reported outcomes and patient satiisfaction, including but not limited to: HHS, OHS,
WOMAC, SF-12, SF-36, EQ-5D, range of motion
86
Systematic review methodology ctd.
• Study designs included: study design was not restricted. Single case studies, editorials, reviews, news and letters
were excluded as well as publications not in the English language
• Additional inclusion criteria at 2nd pass: following consensus among the entire project team, Mr Anil Gambhir and
other surgeons, including Dr Joel Matta, DePuy Synthes confirmed to only include level I and II studies (see quality
assessment criteria below) and those level III and IV studies with ≥75 patients (or hips if only number of hips reported) who underwent DAA
• Quality assessment criteria: publications were assessed for their level of evidence and graded according to the
following criteria(83)
o Level I: High quality RCTs
o Level II: Lesser quality RCTs or prospective comparative studies
o Level III: Case-control studies or retrospective comparative studies
o Level IV: Case series
o Level V: Expert opinion
87
PRISMA flow diagram for DAA
Database searches: 1,522
Embase: 906
MEDLINE: 501
Cochrane library: 145
Duplicates: 384
Abstracts screened (1st pass): 1,168 Excluded on:
Title/abstract: 998
Disease/indication: 372
Intervention: 269
Language (not English): 161
Review: 110
Study design: 57
Patient population: 26
Animal/in vitro study: 3 Screened by full paper (2nd pass): 170
Excluded on full paper: 106
Total included: 92
53 full publications
39 abstracts
Hand searches: 28
88
Appendices for CORAIL/PINNACLE
• Systematic review
methodology
• Flow diagrams of CORAIL
and PINNACLE systematic
reviews
89
Systematic review methodology
• The systematic review was conducted in stages:
o Stage 1: previous systematic reviews conducted by DePuy Synthes, which used broad inclusion criteria to find all
relevant papers, were reviewed to identify eligible publications
o Stage 2: updated searches were conducted on 12th June 2013 for the CORAIL publications and on 5th June 2013
for the PINNACLE publications to identify relevant publications published between October 2012 and June 2013.
Identified publications were reviewed for inclusion in the systematic review
o Stage 3: additional hand searches were reviewed for inclusion in the systematic review. Searches were also
conducted on 20th August 2015 to update registry data included in the systematic review
• The systematic review included any publication reporting on the CORAIL stem or PINNACLE cup together or in any
combination with other acetabular cups of femoral stems. However, the evidence presented here focuses on studies
that report on the CORAIL stem and PINNACLE cup together
• Outcomes of interest: crude rate of revision, survivorship/CRR, OHS, HHS, WOMAC, pain, stem subsidence, cup
migration, length of hospital stay
90
Flow diagrams for CORAIL and PINNACLE
systematic reviews
Identified from
previous SRs: 32
Identified through
QUOSA search: 39
Excluded: 13 Excluded: 27
Total included from
previous SRs: 19
Total included from
QUOSA search: 12
Conference
searches: 7
Final included publications: 38
Of which CORAIL/PINNACLE hip system:
15
Identified from
previous SRs: 28
Identified through
QUOSA search: 48
Excluded: 17 Excluded: 31
Total included from
previous SRs: 11
Total included from
QUOSA search: 17
Conference
searches: 6
Final included publications: 34
Of which CORAIL/PINNACLE hip system:
15
CORAIL flow diagram PINNACLE flow diagram